Evidence map›Paper›PMID 23665328›Full record

ArticleBiochemical and biophysical research communications2013

Heme oxygenase-1 induction alters chemokine regulation and ameliorates human immunodeficiency virus-type-1 infection in lipopolysaccharide-stimulated macrophages.

Zhao-Hua Zhou, Namita Kumari, Sergei Nekhai, Kathleen A Clouse, Larry M Wahl, Kenneth M Yamada, Subhash Dhawan

Open access · hybridAbstract read
In one paragraph

Article in Biochemical and biophysical research communications, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. Anemia, Iron Status, and HIV: A Systematic Review of the Evidence.Advances in nutrition (Bethesda, Md.) · 2020
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Inhibition of HIV-1 by curcumin A, a novel curcumin analog.Drug design, development and therapy · 2015
    Article
  13. Non-coding RNAs and heme oxygenase-1 in vaccinia virus infection.Biochemical and biophysical research communications · 2014
    Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 1 country.

Zhao-Hua ZhouDivision of Monoclonal Antibodies, Center for Drug Evaluation and Research, Food and Drug Administration, Bethesda, MD, USA.
Namita Kumari
Sergei Nekhai
Kathleen A Clouse
Larry M Wahl
Kenneth M Yamada
Subhash Dhawan
Center for Drug Evaluation and Research · USHoward University · USCenter for Biologics Evaluation and Research · USNational Institute of Dental and Craniofacial Research · USNational Institutes of Health · US

Funding

PROTEOMICS CORE FACILITYG12MD007597 · NIMHD · HOWARD UNIVERSITY · PI SOUTHERLAND, WILLIAM M. · 2012 to 2018
$14.8M
Cell-Surface Interactions in PathogenesisZIADE000719 · NIDCR · NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH · PI YAMADA, KENNETH · 2009 to 2025
$13.5M
Center for Hemoglobin Research in Minorities (CHaRM)P50HL118006 · NHLBI · HOWARD UNIVERSITY · PI NEKHAI, SERGEI · 2013 to 2017
$7.0M
Sickle Cell Disease and Sickle Cell Trait Protection Against HIV-1-infection in Africans and African AmericansR01HL125005 · NHLBI · HOWARD UNIVERSITY · PI MARINA A JEREBTSOVA, SERGEI NEKHAI · 2014 to 2026
$6.7M
Regulation of HIV-1 Transcription by CDK2SC1GM082325 · NIGMS · HOWARD UNIVERSITY · PI NEKHAI, SERGEI · 2008 to 2011
$1.2M
Intramural NIH HHSNHLBI NIH HHS P50 HL118006NHLBI NIH HHS R01 HL125005NIGMS NIH HHS SC1 GM082325NIMHD NIH HHS G12 MD007597
6 · The paper itself

Abstract

We have elucidated a putative mechanism for the host resistance against HIV-1 infection of primary human monocyte-derived macrophages (MDM) stimulated with lipopolysaccharide (LPS). We show that LPS-activated MDM both inhibited HIV-1 entry into the cells and were refractory to post-entry productive viral replication. LPS-treated cells were virtually negative for mature virions as revealed by transmission electron microscopy. LPS activation of MDM markedly enhanced the expression of heme oxygenase-1 (HO-1), a potent inducible cytoprotective enzyme. Increased HO-1 expression was accompanied by elevated production of macrophage inflammatory chemokines (MIP1α and MIP1β) by LPS-activated MDM, significantly decreased surface chemokine receptor-5 (CCR-5) expression, and substantially reduced virus replication. Treatment of cells with HO-1 inhibitor SnPP IX (tin protoporphyrin IX) attenuated the LPS-mediated responses, HIV-1 replication and secretion of MIP1α, MIP1β, and LD78β chemokines with little change in surface CCR-5 expression. These results identify a novel role for HO-1 in the modulation of host immune response against HIV infection of MDM.

Indexed as

Adaptor Proteins, Signal TransducingChemokinesHeme Oxygenase-1HIV-1HIV InfectionsHost-Pathogen InteractionsHumansLipopolysaccharidesMacrophage ActivationMacrophagesReceptors, ChemokineAdaptor Proteins, Signal TransducingChemokinesHeme Oxygenase-1HMOX1 protein, humanLipopolysaccharidesMAPKAP1 protein, humanReceptors, Chemokine

Identifiers

PMID23665328
PMCPMC3992914
OpenAlexW1988619689

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.